Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of 2 New Influenza Virus Reassortants in Adults
NCT03564444Phase 4Completed
- Sponsor
- MedImmune
- Start
- Jun 2018
- Primary completion
- Dec 2018
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of live attenuated influenza vaccine in influenza (2 arms), sponsored by MedImmune. Primary endpoint: Percentage of Participants Reporting Fever (Oral Temperature >= 101 Degrees Fahrenheit). Started Jun 2018; status: completed.
02
Drugs
live attenuated influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT03564444.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03564444.